Infectious cell culture supernatant containing SARS-CoV-2, VOI GRA (XBB.1.16+XBB.1.16.*) first detected in India, strain hCoV-19/Italy/LAZ-INMI-5327/2023, A27S, D405N, D614G, D796Y, E180V, E484A, F486P, F490S, G142D, G25
Infectious cell culture supernatant containing SARS-CoV-2 former VOC Beta GH/501Y.V2 (B.1.351+B.1.351.2+B.1.351.3) first detected in South Africa, strain hCoV-19/Italy/LAZ-INMI-494isl/2021, A243del, A701V, D80A, D215G, D
Infectious cell culture supernatant containing SARS-CoV-2 former VOI Eta G/484K.V3 (B.1.525) first detected in UK/Nigeria, strain hCoV-19/Italy/LAZ-INMI-289isl/2021, Q52R, Δ69-70, Δ144, E484K, Q677H, F888L (S) clade G.
Infectious cell culture supernatant containing SARS-CoV-2, former VOC Gamma GR/501Y.V3 (P.1+P.1.*) first detected in Brazil/Japan, isolate hCoV-19/Italy/LAZ-INMI-216isl/2021, clade GR.
Infectious cell culture supernatant containing SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-115isl/2020, Δ69-70, D614G (S), clade G. This strain is preserved under Viral Storage Medium -80C.
We offer a 5 day training session to colleagues from endemic regions. Participants will visit the Viroscience clinical virology lab, where they will perform all required laboratory and analysis procedures for the quantification rabies virus and neutralizing antibodies.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P4-GII.4/NV-22-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.2/NV-22-006. Material 10-20% fecal material in virus culture medium.